Front. Microbiol.
Frontiers in Microbiology
Front. Microbiol.
1664-302X
Frontiers Media S.A.
10.3389/fmicb.2026.1800393
Correction
Correction: Broad-spectrum inhibition of SARS-CoV-2 variants by dibutyl phthalate through allosteric disruption of Spike-ACE2 interface
Chen Jiafan 2 1
Guo Dekuan 3
Guo Xiaoxuan 1
Zhao Lijun 4
Li Geng 3 5
Liu Helu 4
Wang Shaobo 6 7 *
Lao Zizhao 5 *
Zhu Meiling 1 *
1 Shenzhen Traditional Chinese Medicine Hospital , Shenzhen, Guangdong , China 2 Shenzhen Baoan Women's and Children's Hospital , Shenzhen, Guangdong , China 3 State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangzhou University of Chinese Medicine , Guangzhou , China 4 Shenzhen Clinical College of Integrated Chinese and Western Medicine, Guangzhou University of Chinese Medicine , Shenzhen, Guangdong , China 5 Chinese Medicine Guangdong Laboratory , Hengqin, Guangdong , China 6 Guangzhou National Laboratory, Department of Basic Research, Guangzhou International Bio-Island , Guangzhou , China 7 State Key Laboratory of Respiratory Disease, Guangzhou Laboratory Clinical Base, The First Affiliated Hospital of Guangzhou Medical University , Guangzhou , China
* Correspondence: Shaobo Wang, wang_shaobo@gzlab.ac.cn ; Zizhao Lao, lao_zizhao@163.com ; Meiling Zhu, meilingzhu2020@126.com
16
02
2026
2026
17
1800393
30
01
2026
02
02
2026
Copyright © 2026 Chen, Guo, Guo, Zhao, Li, Liu, Wang, Lao and Zhu.
2026
Chen, Guo, Guo, Zhao, Li, Liu, Wang, Lao and Zhu
https://creativecommons.org/licenses/by/4.0/
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
A Correction on Broad-spectrum inhibition of SARS-CoV-2 variants by dibutyl phthalate through allosteric disruption of Spike-ACE2 interface by Chen, J., Guo, D., Guo, X., Zhao, L., Li, G., Liu, H., Wang, S., Lao, Z., and Zhu, M. (2026). Front. Microbiol. 16:1610775. doi: 10.3389/fmicb.2025.1610775
dibutyl phthalate
SARS-CoV-2
viral entry inhibitor
Spike-ACE2 interaction
cell membrane fusion
site-directed mutagenesis
structure optimization
section-at-acceptance
Virology
In the published article, there was an error in the designation of corresponding authors.
The article has three corresponding authors: Shaobo Wang, Zizhao Lao, and Meiling Zhu.
The original version of this article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Approved by: Frontiers Editorial Office , Frontiers Media SA, Switzerland